These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2936404)

  • 1. Anti-CALLA antibodies identify unique antigens on lymphoid cells and granulocytes.
    Pesando JM; Hoffman P; Martin N; Conrad T
    Blood; 1986 Mar; 67(3):588-91. PubMed ID: 2936404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytological and immunochemical analysis on the common acute lymphoblastic leukemia antigen (CALLA): evidence that CALLA on ALL cells and granulocytes are structurally related.
    Fujimoto J; Ishimoto K; Kiyokawa N; Tanaka S; Ishii E; Hata J
    Hybridoma; 1988 Jun; 7(3):227-36. PubMed ID: 2969365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocytes and cultured human fibroblasts express common acute lymphoblastic leukemia-associated antigens.
    Braun MP; Martin PJ; Ledbetter JA; Hansen JA
    Blood; 1983 Apr; 61(4):718-25. PubMed ID: 6572534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution and modulation of a human leukemia-associated antigen (CALLA).
    Pesando JM; Tomaselli KJ; Lazarus H; Schlossman SF
    J Immunol; 1983 Oct; 131(4):2038-45. PubMed ID: 6225802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characterization of murine monoclonal antibodies against the common acute leukemia antigen (CALLA)].
    Seifert M; Eichler W; Fiebig H
    Allerg Immunol (Leipz); 1990; 36(4):267-76. PubMed ID: 2151502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative levels of CALLA/neutral endopeptidase on normal granulocytes, leukemic cells, and transfected COS-1 cells.
    Tran-Paterson R; Boileau G; Giguère V; Letarte M
    Blood; 1990 Aug; 76(4):775-82. PubMed ID: 2166607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant human B cells express two populations of p24 surface antigens.
    Pesando JM; Hoffman P; Conrad T
    J Immunol; 1986 Apr; 136(7):2709-14. PubMed ID: 3485154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique epitopes of common acute lymphoblastic leukemia antigen detected by new monoclonal antibodies.
    Matsuzaki H; Haruta Y; Fukukawa T; Barcos MP; Seon BK
    Cancer Res; 1987 Apr; 47(8):2160-6. PubMed ID: 2435407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphonuclear neutrophils express the common acute lymphoblastic leukemia antigen.
    Cossman J; Neckers LM; Leonard WJ; Greene WC
    J Exp Med; 1983 Mar; 157(3):1064-9. PubMed ID: 6220104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A monoclonal antibody to common acute lymphoblastic leukemia antigen (CALLA) and its expression on several human tumor cell lines.
    Park WS; Hwang TS; Kim TJ; Park CS; Bae YM; Park SH; Lee SK
    J Korean Med Sci; 1992 Jun; 7(2):147-53. PubMed ID: 1388026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of common acute lymphoblastic leukemia antigen positive cells from normal human bone marrow.
    Hokland P; Nadler LM; Griffin JD; Schlossman SF; Ritz J
    Blood; 1984 Sep; 64(3):662-6. PubMed ID: 6235868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and characterization of fetal hematopoietic cells that express the common acute lymphoblastic leukemia antigen (CALLA).
    Hokland P; Rosenthal P; Griffin JD; Nadler LM; Daley J; Hokland M; Schlossman SF; Ritz J
    J Exp Med; 1983 Jan; 157(1):114-29. PubMed ID: 6571733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered expression of cell surface membrane antigens in a common acute lymphoblastic leukemia-associated antigen-expressing neuroblastoma cell line (SJ-N-CG) with morphological differentiation.
    Sugimoto T; Sawada T; Negoro S; Kidowaki T; Morioka H; Matsumura T; Kemshead JT; Seeger RC
    Cancer Res; 1985 Jan; 45(1):358-64. PubMed ID: 2981159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of several cell surface proteins of non-T, non-B acute lymphoblastic leukemia by using monoclonal antibodies.
    Quackenbush EJ; Letarte M
    J Immunol; 1985 Feb; 134(2):1276-85. PubMed ID: 3155538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rat AL2, AL3, AL4 and AL5 monoclonal antibodies bind to the common acute lymphoblastic leukaemia antigen (CALLA gp 100).
    Lebacq-Verheyden AM; Ravoet AM; Bazin H; Sutherland DR; Tidman N; Greaves MF
    Int J Cancer; 1983 Sep; 32(3):273-9. PubMed ID: 6576989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a monoclonal antibody (A12) that defines a human acute lymphoblastic leukemia-associated differentiation antigen.
    Carrel S; Heumann D; Sekaly RP; Zaech P; Buchegger F; Girardet C
    Hybridoma; 1983; 2(2):149-60. PubMed ID: 6205973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fate of a common acute lymphoblastic leukemia antigen during modulation by monoclonal antibody.
    Pesando JM; Ritz J; Lazarus H; Tomaselli KJ; Schlossman SF
    J Immunol; 1981 Feb; 126(2):540-4. PubMed ID: 6935296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of common acute lymphoblastic leukemia antigen (CALLA) on human malignant melanoma cell lines.
    Carrel S; Schmidt-Kessen A; Mach JP; Heumann D; Girardet C
    J Immunol; 1983 May; 130(5):2456-60. PubMed ID: 6339629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subpopulations of common acute lymphoblastic leukemia antigen-positive lymphoid cells in normal bone marrow identified by hematopoietic differentiation antigens.
    Ryan D; Kossover S; Mitchell S; Frantz C; Hennessy L; Cohen H
    Blood; 1986 Aug; 68(2):417-25. PubMed ID: 2942198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative variation of the common acute lymphoblastic leukemia antigen (gp100) on leukemic marrow blasts.
    Look AT; Melvin SL; Brown LK; Dockter ME; Roberson PK; Murphy SB
    J Clin Invest; 1984 Jun; 73(6):1617-28. PubMed ID: 6233301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.